{"text": ["AbbVie", "Presents", "New", "Positive", "Late-Breaking", "Data", "from", "Two", "Phase", "3", "Psoriasis", "Trials", "of", "Risankizumab", "at", "the", "2018", "American", "Academy", "of", "Dermatology", "Annual", "Meeting"], "created_at": "2018-02-17 21:50:00"}
{"text": ["AbbVie", "Presents", "New", "Late-Breaking", "Phase", "2b", "Data", "on", "Upadacitinib", "in", "Atopic", "Dermatitis", "at", "the", "2018", "American", "Academy", "of", "Dermatology", "Annual", "Meeting"], "created_at": "2018-02-17 21:00:00"}
{"text": ["This", "Stock", "Gets", "a", "Gold", "Medal", "for", "Being", "the", "Best", "Blue", "Chip", "Biotech"], "created_at": "2018-02-17 17:06:57"}
{"text": ["This", "Stock", "Gets", "a", "Gold", "Medal", "for", "Being", "the", "Best", "Blue", "Chip", "Biotech"], "created_at": "2018-02-17 17:06:57"}
{"text": ["This", "Stock", "Gets", "a", "Gold", "Medal", "for", "Being", "the", "Best", "Blue", "Chip", "Biotech"], "created_at": "2018-02-17 15:45:00"}
{"text": ["The", "Hottest", "Investing", "Plays", "in", "the", "Booming", "Weed", "Industry", "for", "2018"], "created_at": "2018-02-17 01:00:00"}
